✦ LIBER ✦

Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma

✍ Scribed by A.M. Roguedas; H. Watier; G. Paintaud; A. De Muret; L. Vaillant; L. Machet

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic eight-cycle anti-CD20 monoclona

✍ S. Gellrich; J.M. Muche; A. Wilks; K.C. Jasch; C. Voit; T. Fischer; H. Audring; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Treatment of radiation-relapsing primary

✍ M. E. Lacouture; J. M. Baron; A. B Jani; A. E Laumann; K Soltani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Reduction of tumor burden and stabilizat

✍ Lucie M. Heinzerling; Margarete Urbanek; Jens O. Funk; Stefan Peker; Oliver Blec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

Intralesional and intravenous treatment

✍ K. Kerl; C. Prins; J.H. Saurat; L.E. French 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

B cell-targeted therapy with anti-CD20 m

✍ I. Ueki; N. Abiru; M. Kobayashi; M. Nakahara; T. Ichikawa; K. Eguchi; Y. Nagayam 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

The efficacy and safety of B-cell deplet

✍ Nichola Cooper; Roberto Stasi; Susanna Cunningham-Rundles; Michael A. Feuerstein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB